TMCnet News
Tetraphase Pharmaceuticals to Present at Upcoming Investor ConferencesWATERTOWN, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced that President and Chief Executive Officer Guy Macdonald will present a corporate overview at the Stifel 2018 Healthcare Conference on Wednesday, November 14, 2018 at 8:00 a.m. ET at Lotte New York Palace Hotel in New York City. Mr. Macdonald also will participate in a fireside chat at the Piper Jaffray 30th Annual Healthcare Conference on Tuesday, November 27, 2018 at 2:30 p.m. ET at the Lotte New York Palace Hotel in New York City. A live audio webcast of the Stifel 2018 Healthcare Conference preentation will be available on the Company’s website at https://tphase.gcs-web.com/events-presentations. The archived presentation will be available for 30 days. About Tetraphase Pharmaceuticals, Inc. Media and Investor Contact: |